Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03430921 · ClinicalTrials.gov registry record · NA
Evaluation of the Cutera Enlighten™ Laser With Micro-Lens Array (MLA) Handpiece Attachment
A NA study, sponsored by Cutera.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT03430921 is a NA study that has completed, run by Cutera. The registered enrollment target is 4 participants.
The verdict
NCT03430921, a NA study, has completed, sponsored by Cutera.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this pivotal investigation is to evaluate the efficacy and safety of the Cutera enlighten multi-wavelength 532 nm and 1064 nm picosecond pulse duration laser and an investigational micro-lens array (MLA) handpiece attachment for improvement of moderate to severe acne scars.
Interventions
- DEVICE Enlighten™ Laser and a MLA Attachment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2017-08-15 |
| Est. Completion | 2018-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03430921
The ClinicalTrials.gov registry entry for NCT03430921 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cutera, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Enlighten™ Laser and a MLA Attachment is the first listed.
NCT03430921 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03430921 about?
NCT03430921 is a clinical study titled "Evaluation of the Cutera Enlighten™ Laser With Micro-Lens Array (MLA) Handpiece Attachment". The purpose of this pivotal investigation is to evaluate the efficacy and safety of the Cutera enlighten multi-wavelength 532 nm and 1064 nm picosecond pulse duration laser and an investigational micro-lens array (MLA) handpiece attachment for improvement of moderate to severe acne scars.
What is the current status of trial NCT03430921?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2017-08-15. Estimated completion is 2018-05-30.
What interventions are being tested in trial NCT03430921?
The interventions under investigation include: Enlighten™ Laser and a MLA Attachment (DEVICE).
Who is sponsoring clinical trial NCT03430921?
This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.